A prepackaged injectable pharmaceutical composition includes a sealed outer package made of a material having a low oxygen transmission rate and an inner package disposed within the sealed outer package. The inner package is configured to provide an indication that the inner package has been opened after being closed. A prefilled syringe is disposed within the inner package. The syringe includes a barrel comprising a polymeric material and a dose of the injectable pharmaceutical composition.

Device for blood container processing having a data storage reader unit 20 being adapted to read an blood donator identifier from a data storage of a blood container, and a data processing unit 50 being adapted to request for blood donator related information from an data base 163 based on the read blood donator identifier to allow a correct processing of all relevant information with respect to a blood donator and a blood recipient, to match the blood correctly and to avoid any serious injuries on the blood recipient side.

A mist inhaler device (200) for generating a mist including a therapeutic for inhalation by a user. The device includes a mist generator device (201) and a driver device (202). The driver device (202) is configured to drive the mist generator device (201) at an optimum frequency to maximise the efficiency of mist generation by the mist generator device (201).

A treatment system (100) for treating a patient comprises a medical device (10) and a portable authentication device (20), wherein the medical device (10) is adapted to output an acoustic signal when a wireless communication connection between the medical device (10) and the portable authentication device (20) is successfully established, the portable authentication device (20) is adapted to receive the acoustic signal, to generate, based on the received acoustic signal, a signal containing a signal corresponding to the received acoustic signal, and to wirelessly transmit the generated signal to the medical device (10), and the medical device (10) is adapted to determine whether or not the portable authentication device (20) is located at a position where acoustic communication between the medical device (10) and the portable authentication device (20) is possible, depending on whether or not it receives the signal containing the signal corresponding to the acoustic signal received by the portable authentication device (20).

In part, the disclosure relates to a safety monitor and related methods to evaluate and manage intrapartum uterine contractions induced or augmented by Pitocin or other contraction inducing agents. The systems and methods include measuring a contraction parameter that may include one or more of frequency, strength, and duration of uterine contractions through a measurement device connected to a monitor. The systems and methods are programmed to stop the pump-based administration of a contraction inducing agent. Various lock out protocols and control over the ability to re-start a given pump are also described herein.

Systems, devices, and techniques are disclosed for administering and tracking medicine to patients and providing health management capabilities for patients and caregivers. In some aspects, a method includes receiving one or more analyte values associated with a health condition of the patient user; receiving contextual data associated with the patient user obtained by the mobile computing device, where the obtained contextual data includes information associated with a meal; determining a medicine metric value associated with an amount of medicine active in the body of the patient user; autonomously calculating a dose of the medicine without input from the user based at least on the one or more analyte values, the medicine metric value, and the information associated with a meal; and continuously displaying the calculated dose of the medicine.

Drug depot delivery devices and methods for delivering a drug depot to a site beneath the skin of a patient are provided. In various embodiments the device has a housing having a top housing end, and a bottom housing end. The housing defines a housing channel. The device has a drug cartridge defining a depot channel aligned with the housing channel and configured to slidably accept the drug depot. The drug cartridge has at least a first occluding device configured to occlude the depot channel at a first position such that the drug depot cannot pass through the depot channel without force applied to the drug depot sufficient to deflect the first occluding device. The bottom end of the housing has a coupling configuration for engaging a cannula. A plunger has a push rod to expel the drug depot through the occluding device and the cannula.

A packaging line implemented for packaging a pre-filled syringe is disclosed having a NSD mounting station, a PFS delivery arrangement adapted to automatically deliver a pre-filled syringe to the NSD mounting station, and a NSD delivery arrangement adapted to automatically deliver a needle safety device to the NSD mounting station. The NSD mounting station is arranged to automatically assemble the needle safety device to the pre-filled syringe. A NSD visual inspection station is adapted to automatically identify a pre-filled syringe with an unfit needle safety device and to automatically eliminate the identified pre-filled syringe from the packaging line. A re-insertion station is further provided to receive a pre-filled syringe with a needle safety device and to automatically feed the received pre-filled syringe, preferably from a rejected secondary packaging, back into the packaging line, after the NSD mounting station and before the NSD visual inspection station.

Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.

Embodiments provide an oxygen supply device having multiple operational states including a first state and a second state. In the first state, the oxygen supply device is controllable to a local control instruction such that the oxygen supply device can be operated by a user physically located within a proximity of the oxygen supply device. In the second state, the oxygen supply device is only controllable to a remote-control instruction such that the oxygen supply device can be operated by a user remote to the oxygen supply device. For example, the user can be located in an office remote to a location of the oxygen supply device, which, for example, may be placed at a patient's home. In the second state, the user is enabled to control the oxygen supply device from a device associated with the user in the remote location.